1-7 of 7
Jouke T. Tamsma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes

Jacqueline T. Jonker, MD, Yanan Wang, MSC, Willeke de Haan, PHD, Michaela Diamant, MD, PHD, Luuk J. Rijzewijk, MD, Rutger W. van der Meer, MD, PHD, Hildo J. Lamb, MD, PHD, Jouke T. Tamsma, MD, PHD, Albert de Roos, MD, PHD, Johannes A. Romijn, MD, PHD, Patrick C.N. Rensen, PHD, Johannes W.A. Smit, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(7):1625–1628
https://doi.org/10.2337/dc09-1935
Published: 11 February 2010
View article titled, Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes
Open the PDF for Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes in another window
Journal Articles

Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome

Rachel L.M. van der Ham, MD, Reza Alizadeh Dehnavi, MD, Jimmy F.P. Berbée, PHD, Hein Putter, PHD, Albert de Roos, MD, PHD, Johannes A. Romijn, MD, PHD, Patrick C.N. Rensen, PHD, Jouke T. Tamsma, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(1):184–186
https://doi.org/10.2337/dc08-1330
Published: 01 January 2009
View article titled, Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome
Open the PDF for Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome in another window
Includes: Supplementary data
Journal Articles

Assessment of Aortic Pulse Wave Velocity and Cardiac Diastolic Function in Subjects With and Without the Metabolic Syndrome: HDL cholesterol is independently associated with cardiovascular function

Stijntje D. Roes, MD, Reza Alizadeh Dehnavi, MD, Jos J.M. Westenberg, PHD, Hildo J. Lamb, MD, Bart J.A. Mertens, PHD, Jouke T. Tamsma, MD, Albert de Roos, MD
Journal: Diabetes Care
Diabetes Care 2008;31(7):1442–1444
https://doi.org/10.2337/dc08-0055
Published: 01 July 2008
View article titled, Assessment of Aortic Pulse Wave Velocity and Cardiac Diastolic Function in Subjects With and Without the Metabolic Syndrome: <subtitle>HDL cholesterol is independently associated with cardiovascular function</subtitle>
Open the PDF for Assessment of Aortic Pulse Wave Velocity and Cardiac Diastolic Function in Subjects With and Without the Metabolic Syndrome: <subtitle>HDL cholesterol is independently associated with cardiovascular function</subtitle> in another window
Journal Articles

The Effect of Statin Therapy on Endothelial Function in Type 2 Diabetes Without Manifest Cardiovascular Disease

Edith D. Beishuizen, MD, Jouke T. Tamsma, MD, PHD, J. Wouter Jukema, MD, PHD, Marcel A. van de Ree, MD, PHD, J. Carel M. van der Vijver, MD, PHD, A. Edo Meinders, MD, PHD, Menno V. Huisman, MD, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(7):1668–1674
https://doi.org/10.2337/diacare.28.7.1668
Published: 01 July 2005
View article titled, The Effect of Statin Therapy on Endothelial Function in Type 2 Diabetes Without Manifest Cardiovascular Disease
Open the PDF for The Effect of Statin Therapy on Endothelial Function in Type 2 Diabetes Without Manifest Cardiovascular Disease in another window
Journal Articles

No Effect of Statin Therapy on Silent Myocardial Ischemia in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease

Edith D. Beishuizen, MD, J. Wouter Jukema, MD, PHD, Jouke T. Tamsma, MD, PHD, Marcel A. van de Ree, MD, PHD, J. Carel M. van der Vijver, MD, PHD, Hein Putter, PHD, Arie C. Maan, PHD, A. Edo Meinders, MD, PHD, Menno V. Huisman, MD, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(7):1675–1679
https://doi.org/10.2337/diacare.28.7.1675
Published: 01 July 2005
View article titled, No Effect of Statin Therapy on Silent Myocardial Ischemia in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease
Open the PDF for No Effect of Statin Therapy on Silent Myocardial Ischemia in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease in another window
Journal Articles

Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardio-vascular Disease: Response to Cicero et al.

Edith D. Beishuizen, MD, Marcel A. van de Ree, MD, PHD, J. Wouter Jukema, MD, PHD, Jouke T. Tamsma, MD, PHD, Menno V. Huisman, MD, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(5):1263–1264
https://doi.org/10.2337/diacare.28.5.1263
Published: 01 May 2005
View article titled, Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardio-vascular Disease: <subtitle>Response to Cicero et al.</subtitle>
Open the PDF for Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardio-vascular Disease: <subtitle>Response to Cicero et al.</subtitle> in another window
Journal Articles

Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease

Edith D. Beishuizen, MD, Marcel A. van de Ree, MD, PHD, J. Wouter Jukema, MD, PHD, Jouke T. Tamsma, MD, PHD, J. Carel M. van der Vijver, MD, PHD, A. Edo Meinders, MD, PHD, Hein Putter, PHD, Menno V. Huisman, MD, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(12):2887–2892
https://doi.org/10.2337/diacare.27.12.2887
Published: 01 December 2004
View article titled, Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease
Open the PDF for Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease in another window